| Dr Ronald Glenn Hess, DO | |
|
500 E Business Way, Cincinnati, OH 45241-2374 | |
| (513) 354-3700 | |
| (513) 354-3705 |
| Full Name | Dr Ronald Glenn Hess |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 33 Years |
| Location | 500 E Business Way, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023018348 | NPI | - | NPPES |
| 000000075003 | Other | OH | ANTHEM |
| 8892244001 | Other | OH | CIGNA |
| 200036019 | Other | OH | MEDICARE RAILROAD |
| 0901348 | Other | OH | UNITED HEALTHCARE |
| 0892119 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 34.005593 (Ohio) | Secondary |
| 207X00000X | Orthopaedic Surgery | 34-00-5593 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health - Fairfield Hospital | Fairfield, OH | Hospital |
| Mccullough-hyde Memorial Hospital | Oxford, OH | Hospital |
| Christ Hospital | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Orthopaedics And Sports Medicine Ltd | 0345136412 | 438 |
News Archive
An e-mail intervention program is an effective way to significantly improve diet and physical activity by helping people move more, sit less, and make healthier food choices, according to a Kaiser Permanente Division of Research study in the American Journal of Preventive Medicine.
The study, presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians (ACCP), showed that statins notably reduced such incidences in these nonrevascularized patients with chronic high cholesterol, as well.
Exposure to high levels of traffic-related air pollution is associated with changes in the right ventricle of the heart that may contribute to the known connection between air pollution exposure and heart disease, according to a new study.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.
› Verified 6 days ago
| Entity Name | Beacon Orthopaedics & Sports Medicine Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386670065 PECOS PAC ID: 0345136412 Enrollment ID: O20040225000690 |
News Archive
An e-mail intervention program is an effective way to significantly improve diet and physical activity by helping people move more, sit less, and make healthier food choices, according to a Kaiser Permanente Division of Research study in the American Journal of Preventive Medicine.
The study, presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians (ACCP), showed that statins notably reduced such incidences in these nonrevascularized patients with chronic high cholesterol, as well.
Exposure to high levels of traffic-related air pollution is associated with changes in the right ventricle of the heart that may contribute to the known connection between air pollution exposure and heart disease, according to a new study.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald Glenn Hess, DO 6480 Harrison Ave Ste 201, Cincinnati, OH 45247-7961 Ph: (513) 354-3700 | Dr Ronald Glenn Hess, DO 500 E Business Way, Cincinnati, OH 45241-2374 Ph: (513) 354-3700 |
News Archive
An e-mail intervention program is an effective way to significantly improve diet and physical activity by helping people move more, sit less, and make healthier food choices, according to a Kaiser Permanente Division of Research study in the American Journal of Preventive Medicine.
The study, presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians (ACCP), showed that statins notably reduced such incidences in these nonrevascularized patients with chronic high cholesterol, as well.
Exposure to high levels of traffic-related air pollution is associated with changes in the right ventricle of the heart that may contribute to the known connection between air pollution exposure and heart disease, according to a new study.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.
› Verified 6 days ago
Brendan Michael Swift, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4700 E Galbraith Rd., Suite 300a, Cincinnati, OH 45236 Phone: 513-347-9999 Fax: 513-686-4217 | |
Dr. John Michael Gallagher, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3650 Muddy Creek Rd, Suite 100, Cincinnati, OH 45238 Phone: 513-451-0500 Fax: 513-451-0210 | |
Dr. George Theodore Shybut, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4440 Glen Este Withamsville Rd, Suite 500, Cincinnati, OH 45245 Phone: 513-753-7488 Fax: 513-753-7879 | |
Dr. Michael T Rohmiller, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 E Business Way, Suite A, Cincinnati, OH 45241 Phone: 513-354-3700 Fax: 513-354-7651 | |
Keith Girton, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 644 Eden Park Dr, Cincinnati, OH 45202 Phone: 513-572-8670 Fax: 513-572-8489 | |
Dr. Alvin C Jones, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3333 Burnet Ave. Ml 2023, Cincinnati, OH 45229 Phone: 513-636-4371 Fax: 513-636-7657 |